Purdue
Loses Case To Stop Generic OxyContin
By Andrew Karpan
The bankrupt
Purdue Pharma lost its legal effort to use patent laws to block an Indian
drugmaker from launching a generic version of OxyContin when a federal judge in
Delaware decided on Tuesday that some of the patents covering the drug's newer
"abuse-deterrent" features could be found in decade-old academic
articles and patent paperwork.
Order
attached | Read full article »
No comments:
Post a Comment